Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Child & Adolescent Psychiatry
Published in: European Child & Adolescent Psychiatry 8/2009

01-08-2009 | Case Report

Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders

Authors: Fatma Varol Tas, Taner Guvenir

Published in: European Child & Adolescent Psychiatry | Issue 8/2009

Login to get access

Abstract

In this article, our aim was to share our clinical experience regarding the effectiveness and the side effects of amisulpride treatment in adolescent cases. We reviewed all the cases who had amisulpride treatment during their stay in a newly opened in-patient unit, and three female cases who had undergone amisulpride treatment. We observed that the drug was effective and caused side effects like galactorrhea due to increased prolactin levels, which were not severe enough to terminate the treatment. Our clinical experience provides preliminary evidence that amisulpride might be an effective antipsychotic drug for adolescent cases. However, it caused considerable side effects.
Literature
1.
Colonna L, Saleem P, Dondey-Nouvel L, Rein W (2000) Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group. Int Clin Psychopharmacol 15:13–22PubMedCrossRef
2.
Jensen PS, Buitelaar J, Pandina GJ, Binder C, Haas M (2007) Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials. Eur Child Adolesc Psychiatry 16:104–120PubMedCrossRef
3.
Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IPM et al (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet 371:1085–1097PubMedCrossRef
4.
McKeage K, Plosker GL (2004) Amisulpride: a review of its use in the management of schizophrenia. CNS Drugs 18:933–956PubMedCrossRef
5.
Mortimer A, Martin S, Lôo H, Peuskens J, for the Solianol Study Group (2004) A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. Int Clin Psychopharmacol 19:63–69
6.
Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O et al (2002) Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia. J Clin Psychopharmacol 22:554–560PubMedCrossRef
7.
Nuss P, Hummer M, Tessier C (2007) The use of amisulpride in the treatment of acute psychosis. Ther Clin Risk Manag 3(1):3–11PubMedCrossRef
8.
Sechter D, Peuskens J, Fleurot O, Rein W, Lecrubier Y, Amisulpride Study Group (2002) Amisulpride vs. Risperidone in chronic schizophrenia: results of a 6-month double-blind study. Neuropsychopharmacology 27:1071–1081
9.
Volkmar FR, Tsatsanis KD (2002) Childhood schizophrenia. In: Lewis M (ed) Child and adolescent psychiatry. A comprehensive textbook. Lippincott Williams & Wilkins, Philadelphia, pp 745–754
Metadata
Title
Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders
Authors
Fatma Varol Tas
Taner Guvenir
Publication date
01-08-2009
Publisher
D. Steinkopff-Verlag
Published in
European Child & Adolescent Psychiatry / Issue 8/2009
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI
https://doi.org/10.1007/s00787-009-0009-8

Other articles of this Issue 8/2009

European Child & Adolescent Psychiatry 8/2009 Go to the issue

Original Contribution

Impulsivity-hyperactivity and subtypes of aggression in early childhood: an observational and short-term longitudinal study

Brief Report

Autism spectrum disorders in children and adolescents with Moebius sequence

Original Contribution

Screening for children’s depression symptoms in Greece: the use of the Children’s Depression Inventory in a nation-wide school-based sample

Brief Report

The construction and validation of a short form of the developmental, diagnostic and dimensional interview

Original Contribution

When does the Autism Spectrum Screening Questionnaire (ASSQ) predict autism spectrum disorders in primary school-aged children?

Original Contribution

Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study